CRISPR Therapeutics AG (CRSP)
51.14
-2.46
(-4.60%)
USD |
NASDAQ |
May 10, 16:00
51.25
+0.12
(+0.22%)
After-Hours: 20:00
CRISPR Therapeutics Shares Outstanding: 84.88M for April 8, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
April 08, 2024 | 84.88M |
March 15, 2024 | 84.75M |
February 16, 2024 | 80.28M |
December 31, 2023 | 80.04M |
November 02, 2023 | 79.43M |
September 30, 2023 | 79.43M |
August 03, 2023 | 79.41M |
June 30, 2023 | 79.37M |
May 05, 2023 | 78.94M |
April 17, 2023 | 78.89M |
March 31, 2023 | 78.86M |
February 16, 2023 | 78.65M |
December 31, 2022 | 78.51M |
October 28, 2022 | 78.29M |
September 30, 2022 | 78.25M |
August 04, 2022 | 78.01M |
June 30, 2022 | 77.79M |
May 05, 2022 | 77.46M |
April 18, 2022 | 77.40M |
March 31, 2022 | 77.39M |
March 15, 2022 | 77.20M |
February 11, 2022 | 77.07M |
December 31, 2021 | 76.99M |
November 01, 2021 | 76.53M |
September 30, 2021 | 76.46M |
Date | Value |
---|---|
July 27, 2021 | 76.20M |
June 30, 2021 | 76.08M |
April 23, 2021 | 75.77M |
April 16, 2021 | 75.76M |
March 31, 2021 | 75.73M |
March 15, 2021 | 75.61M |
February 11, 2021 | 75.43M |
January 15, 2021 | 75.13M |
December 31, 2020 | 73.91M |
November 30, 2020 | 71.21M |
October 23, 2020 | 70.65M |
September 30, 2020 | 70.60M |
July 23, 2020 | 70.17M |
July 06, 2020 | 71.44M |
June 30, 2020 | 64.05M |
June 15, 2020 | 61.96M |
June 11, 2020 | 64.24M |
April 24, 2020 | 61.02M |
April 13, 2020 | 61.01M |
March 31, 2020 | 60.89M |
March 15, 2020 | 60.89M |
February 07, 2020 | 60.85M |
December 31, 2019 | 60.78M |
December 20, 2019 | 61.08M |
November 25, 2019 | 60.44M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
53.50M
Minimum
Jun 30 2019
84.88M
Maximum
Apr 08 2024
71.62M
Average
75.76M
Median
Shares Outstanding Benchmarks
Vertex Pharmaceuticals Inc | 258.05M |
Intellia Therapeutics Inc | 96.11M |
Novartis AG | 2.040B |
AC Immune SA | 98.90M |
Addex Therapeutics Ltd | 1.069M |